(1) Jiaojiao Yu#, Dandan Zhou#, Xiaoxiao Yang, Bing Cui, Fengwei Tan, Junjian Wang, Ke Li, Shuang Shang, Cheng Zhang, Xiaoxi Lv, Xiaowei Zhang, Shanshan Liu, Jinmei Yu, Feng Wang, Bo Huang, Fang Hua* & Zhuowei Hu*. TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target. Nature Communications, 2020, 11(1): 3660.
(2) Jiaojiao Yu#, Dandan Zhou#, Bing Cui, Cheng Zhang, Fengwei Tan, Shan Chang, Ke Li, Xiaoxi Lv , Xiaowei Zhang, Shuang Shang, Yujin Xiang, Fei Chen, Jinmei Yu, Shanshan Liu, Feng Wang, Zhuowei Hu* & Fang Hua*, Disruption of the EGFR-SQSTM1 Interaction by a Stapled Peptide Suppresses Lung Cancer via Activating Autophagy and Inhibiting EGFR Signaling, Cancer Letters, 2020, 474: 23-35.
(3) Fang Hua#, Ke Li#, Jiaojiao Yu#, Xiaoxi Lv, Jun Yan, Xiaowei Zhang, Wei Sun, Heng Lin, Shuang Shang, Feng Wang, Bing Cui, Rong Mu, Bo Huang, Jiandong Jiang, Zhuowei Hu*, TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations, Nature Communications, 2015, 6: 7951.
(4) 余娇娇, 张诚, 向昱瑾, 胡卓伟, 崔冰*, 花芳*. TRIB3激活NRF2促进肺癌细胞增殖并抑制其凋亡. 药学学报, 2021,56(5): 1352-1359.